Creates a new “Abraham Accords Office” inside the Food and Drug Administration to deepen regulatory cooperation with countries that are part of the Abraham Accords. The Secretary of Health and Human Services, through the FDA Commissioner, must set up the office, choose a host country in the region within two years, and staff it.

The office will provide technical assistance and coordination consistent with FDA’s mission. Within three years, the Department must report to Congress on the office’s activities and recommendations. The measure does not change FDA approval standards or appropriate new funding.